Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hydralazine measurement |
Component |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine poisoning (disorder) |
Causative agent (attribute) |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental hydralazine poisoning |
Causative agent (attribute) |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional hydralazine poisoning |
Causative agent (attribute) |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydralazine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine adverse reaction |
Causative agent (attribute) |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to hydralazine |
Causative agent (attribute) |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydralazine overdose (disorder) |
Causative agent (attribute) |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental hydralazine overdose |
Causative agent (attribute) |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional hydralazine overdose |
Causative agent (attribute) |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine overdose of undetermined intent |
Causative agent (attribute) |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydralazine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydralazine hydrochloride 20mg injection (pdr for recon) (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydralazine hydrochloride + hydrochlorothiazide 100mg/50mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydralazine hydrochloride 50 mg and hydrochlorothiazide 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drug-induced lupus erythematosus caused by hydralazine (disorder) |
Causative agent (attribute) |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine-induced pericarditis |
Causative agent (attribute) |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydralazine hydrochloride |
Is a |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental hydralazine poisoning |
Causative agent (attribute) |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional hydralazine poisoning |
Causative agent (attribute) |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine- and isosorbide dinitrate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydralazine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to hydralazine |
Causative agent (attribute) |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing hydralazine and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine-induced pericarditis |
Causative agent (attribute) |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydralazine hydrochloride |
Is modification of (attribute) |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing hydralazine and isosorbide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing hydralazine and isosorbide in oral dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing hydralazine and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine- and hydrochlorothiazide- and reserpine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine- and hydrochlorothiazide- and reserpine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only hydralazine and isosorbide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only hydralazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine and hydrochlorothiazide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine and hydrochlorothiazide and reserpine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only hydralazine and isosorbide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydralazine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine and hydrochlorothiazide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine-induced pericarditis |
Causative agent (attribute) |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine- and isosorbide dinitrate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only hydralazine and isosorbide dinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine- and isosorbide dinitrate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydralazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |